García-Romero E, del Val A, Garrigues V, Cuquerella J, Higón M D, Barrachina M, Pons V, Bixquert M, Ponce J
Hospital Gran Vía, Valencia.
Gastroenterol Hepatol. 1999 Jan;22(1):1-6.
To investigate the eradication rate of Helicobacter pylori with omeprazole, amoxicillin and clarithromycin during 6 days in patients with duodenal ulcer. To compare the reliability of the analysis of the eradication with urea-13C breath test performed one month and 3 months after therapy. To evaluate the one-year reinfection rate.
Prospective study including 99 patients with duodenal ulcer (65 with acute disease and 34 in maintenance treatment) infected by Helicobacter pylori (urease rapid test and urea-13C breath test positive). Patients were treated with omeprazole 20 mg, clarithromycin 500 mg and amoxicillin 1 g, b.i.d., during 6 days. The infection status was investigated 1 and 3 months after treatment by urea-13C breath test. The one-year reinfection rate was investigated using the same test.
Per protocol eradication rates were 76% (95%-CI: 66-84) one month and 73% (95%-CI: 63-81) 3 months after treatment. In the intention to treat analysis, eradication rates were 74% (95%-CI: 64-82) and 70% (95%-CI: 60-79), respectively. Side effects were mild and uncommon. The rate of false negative urea-13C breath test results one month after therapy with respect to 3 months was 4.2% (95%-CI: 0.8-11.7). One-year reinfection rate determined in 56 patient was absent.
The eradication of Helicobacter pylori with triple therapy for 6 days in patients with duodenal ulcer is not satisfactory. To investigate Helicobacter pylori infection with urea-13C breath test one month after treatment overestimates the results of the eradication. One-year reinfection rate is clinically irrelevant.
研究十二指肠溃疡患者使用奥美拉唑、阿莫西林和克拉霉素治疗6天对幽门螺杆菌的根除率。比较治疗后1个月和3个月进行的尿素-13C呼气试验分析根除情况的可靠性。评估一年的再感染率。
前瞻性研究纳入99例幽门螺杆菌感染(尿素酶快速试验和尿素-13C呼气试验阳性)的十二指肠溃疡患者(65例急性病患者和34例维持治疗患者)。患者接受奥美拉唑20mg、克拉霉素500mg和阿莫西林1g,每日2次,共治疗6天。治疗后1个月和3个月通过尿素-13C呼气试验调查感染状况。使用相同试验调查一年的再感染率。
根据方案分析,治疗后1个月的根除率为76%(95%可信区间:66-84),3个月为73%(95%可信区间:63-81)。在意向性治疗分析中,根除率分别为74%(95%可信区间:64-82)和70%(95%可信区间:60-79)。副作用轻微且不常见。治疗后1个月相对于3个月尿素-13C呼气试验结果的假阴性率为4.2%(95%可信区间:0.8-11.7)。在56例患者中确定的一年再感染率为零。
十二指肠溃疡患者使用三联疗法治疗6天对幽门螺杆菌的根除效果不理想。治疗后1个月用尿素-13C呼气试验调查幽门螺杆菌感染会高估根除结果。一年的再感染率在临床上无意义。